Spain, June 5 -- Spain based UCB PHARMA, S.A has secured contract from Direccion Gerencia Hospital Universitario de Gran Canaria Doctor Negrin for Various Medicinal Products - The object of the contract is determined by the supply of the active substance called "bimekizumab". The value of the contract is worth 25738932 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....